REGN646 in cynomolgus monkeys: 5-week IV infusion, 13-week SC, and 6-month IV and SC studies
“The three pivotal repeat dose toxicity studies, including a 5-week intravenous infusion (IV), a 13-week subcutaneous (SC) and a 6-month IV and SC studies, were conducted with REGN646”
✓ VerifiedFDA pharmacology/toxicology review, p. 6Source ↗
Route in tox
Subcutaneous and intravenous
“once weekly IV or SC treatment with REGN646 at doses up to 100 mg/kg was well tolerated”